ARTICLE | Company News
Merus, OcellO deal
January 21, 2013 8:00 AM UTC
The companies partnered to screen human bispecific antibodies from Merus - called Biclonics - for cancer. OcellO will use its 3D cell culture-based screening technology to screen undisclosed Biclonics...